Key result
Acetylsalicylic acid plus dipyridamole reduced the incidence of death from all causes or strokes by 33.5% compared to placebo in patients with previous cerebrovascular disorders.
Why the study?
Does acetylsalicylic acid plus dipyridamole reduce deaths from all causes or strokes in patients with previous cerebrovascular disorders?
RCT (n=2,500)
Does acetylsalicylic acid plus dipyridamole reduce deaths from all causes or strokes in patients with previous cerebrovascular disorders?
Combination therapy with acetylsalicylic acid and dipyridamole significantly reduces the risk of death or stroke in patients with prior cerebrovascular events compared to placebo.
Answers are grounded in this paper and cite their sources.
May support dual antiplatelet therapy post-stroke; leaves open confirmation in contemporary randomized trials.
We compared the outcomes of 2,500 patients who suffered from previous cerebrovascular disorders (transient ischemic attacks, reversible ischemic neurologic deficits, or completed strokes) treated with acetylsalicylic acid plus dipyridamole or matched placebo and followed for 2 years. Treatment was associated with a 33.5% reduction (p less than 0.001) in the incidence of all end points (deaths from all causes or strokes) by intention-to-treat analysis and a 36.5% reduction (p less than 0.001) by explanatory analysis. End point reduction appeared to be similar in men and women. The effect of treatment was similar regardless of the patients' age, nature of the qualifying cerebrovascular event, site of the responsible lesion, and diastolic blood pressure. Our results demonstrate the efficacy of combined therapy, but the efficacy of acetylsalicylic acid or dipyridamole alone and the most effective acetylsalicylic acid dosage remain in question.
No takes yet. Share an insight, caveat, or question.
A 1990 study conducted an RCT in previous cerebrovascular disorders (n=2,500). acetylsalicylic acid plus dipyridamole vs. matched placebo was evaluated on deaths from all causes or strokes (33.5% reduction, p=<0.001). Acetylsalicylic acid plus dipyridamole reduced the incidence of death from all causes or strokes by 33.5% compared to placebo in patients with previous cerebrovascular disorders.
Synapse has enriched 10 related papers. Consider them for comparative context: